Saudi Arabian Oil Company (2222.SR) vs AbbVie Inc. (ABBV)

Saudi Arabian Oil Company, commonly known as Saudi Aramco, is one of the world’s largest integrated energy companies. It explores for, produces, refines, transports, and markets crude oil, natural gas, petrochemicals, and related products. Aramco’s operations are centered in Saudi Arabia, where it controls some of the largest conventional oil reserves in the world. Its earnings are closely linked to global energy demand, production policy, refining margins, and long-term investment in oil, gas, and downstream chemical assets.

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.